Publications by authors named "Shinya Chihara"

Article Synopsis
  • Aggressive pharmacokinetic/pharmacodynamic (PK/PD) targets for meropenem showed better success in eliminating bacteria and reducing resistance compared to conservative targets.
  • A study evaluated the effectiveness and safety of a 1 g meropenem infusion every 8 hours in patients on continuous renal replacement therapy for septic acute kidney injury, finding an acceptable risk of toxicity.
  • Results indicated that aggressive PK/PD could be achieved for pathogens with a minimal inhibitory concentration (MIC) of up to 0.5 mg/L, with simulation suggesting that continuous infusion at a higher dose could maintain efficacy for MICs of 1-2 mg/L without increasing daily dosage.
View Article and Find Full Text PDF

Objective:: We investigated the differences in biocompatibility pre- and post-dilution during continuous veno-venous hemofiltration in patients with sepsis, focusing on leukocyte and platelet function.

Patients And Methods:: Subjects were 12 patients with septic shock who underwent veno-venous hemofiltration for acute kidney injury between March 2016 and September 2017. The first six patients received pre-dilution veno-venous hemofiltration, and the next six patients received post-dilution veno-venous hemofiltration.

View Article and Find Full Text PDF

We compared the clearance characteristics of low-to-high molecular weight substances during pre-and postdilution continuous venovenous hemofiltration (CVVH) in experimental and clinical conditions. Experimental circuits for pre- and postdilution CVVH were prepared using a test solution containing creatinine (110 Da), inulin (5,000 Da), interleukin (IL)-8 (8,000 Da), IL-6 (22,000 Da), and tumor necrosis factor (TNF)-α (51,000 Da). Quantity of test solution flow and filtration flow (QF) were set to 150 ml/min and 10, 20, and 35 ml/min, respectively.

View Article and Find Full Text PDF

This study was conducted to clarify the effectiveness of induction timing of direct hemoperfusion with a polymyxin-B immobilized column (PMX-DHP) for amelioration of hemodynamic derangement and outcome in patients with septic shock. Suspected Gram-negative septic shock patients who received PMX-DHP therapy from January 2010 to December 2014 in our ICU were enrolled in this study. The patients were divided into two groups that received PMX-DHP therapy within 8 h (early group) and more than 8 h (late group) from catecholamine administration.

View Article and Find Full Text PDF

Prone ventilation is an effective method for improving oxygenation in patients with acute respiratory failure. However, in extracorporeal circulation, there is a risk of cannula-related complications when changing the position. In this study, we investigated cannula-related complications when changing position for prone ventilation and the effect of prone ventilation on impaired oxygenation in patients who underwent extracorporeal membrane oxygenation (ECMO).

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Shinya Chihara"

  • - Shinya Chihara's research focuses on optimizing treatment protocols and monitoring techniques for patients undergoing renal replacement therapy and managing septic conditions, particularly in the context of pharmacokinetics and hemofiltration practices.
  • - Recent studies highlighted the importance of aggressive pharmacokinetic/pharmacodynamic (PK/PD) targets for meropenem in patients with septic acute kidney injury, as well as the comparative efficacy of pre- and post-dilution techniques in continuous venovenous hemofiltration on leukocyte and platelet functions.
  • - Chihara’s investigations also emphasize the impact of treatment timing—in particular, early induction of direct hemoperfusion in septic shock patients—on enhancing hemodynamic stability and potentially reducing mortality rates.